- Home
- HOFT vs NKTX Comparison
HOFT vs NKTX Comparison
Compare HOFT & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOFT
- NKTX
- Stock Information
- Founded
- HOFT 1924
- NKTX 2015
- Country
- HOFT United States
- NKTX United States
- Employees
- HOFT N/A
- NKTX N/A
- Industry
- HOFT Home Furnishings
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- HOFT Consumer Discretionary
- NKTX Health Care
- Exchange
- HOFT Nasdaq
- NKTX Nasdaq
- Market Cap
- HOFT 104.6M
- NKTX 123.5M
- IPO Year
- HOFT 1999
- NKTX 2020
- Fundamental
- Price
- HOFT $9.82
- NKTX $1.74
- Analyst Decision
- HOFT
- NKTX Strong Buy
- Analyst Count
- HOFT 0
- NKTX 6
- Target Price
- HOFT N/A
- NKTX $14.80
- AVG Volume (30 Days)
- HOFT 48.7K
- NKTX 422.6K
- Earning Date
- HOFT 06-12-2025
- NKTX 05-14-2025
- Dividend Yield
- HOFT 9.37%
- NKTX N/A
- EPS Growth
- HOFT N/A
- NKTX N/A
- EPS
- HOFT N/A
- NKTX N/A
- Revenue
- HOFT $397,465,000.00
- NKTX N/A
- Revenue This Year
- HOFT $3.58
- NKTX N/A
- Revenue Next Year
- HOFT $7.66
- NKTX N/A
- P/E Ratio
- HOFT N/A
- NKTX N/A
- Revenue Growth
- HOFT N/A
- NKTX N/A
- 52 Week Low
- HOFT $7.34
- NKTX $1.31
- 52 Week High
- HOFT $19.79
- NKTX $8.23
- Technical
- Relative Strength Index (RSI)
- HOFT 55.02
- NKTX 45.11
- Support Level
- HOFT $8.98
- NKTX $1.70
- Resistance Level
- HOFT $9.74
- NKTX $1.82
- Average True Range (ATR)
- HOFT 0.43
- NKTX 0.10
- MACD
- HOFT 0.04
- NKTX -0.01
- Stochastic Oscillator
- HOFT 54.66
- NKTX 18.82
About HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.